PGFC
CVS icon

Peapack-Gladstone Financial Corp’s CVS Health CVS Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2M Sell
142,327
-1,951
-1% -$150K 0.13% 163
2025
Q4 		$11.4M Sell
144,278
-3,684
-2% -$290K 0.14% 148
2025
Q3 		$11.2M Sell
147,962
-11,143
-7% -$764K 0.15% 145
2025
Q2 		$11M Sell
159,105
-7,569
-5% -$496K 0.16% 142
2025
Q1 		$11.3M Sell
166,674
-3,631
-2% -$217K 0.17% 137
2024
Q4 		$7.65M Sell
170,305
-37,995
-18% -$2.13M 0.11% 169
2024
Q3 		$13.1M Sell
208,300
-44,227
-18% -$2.58M 0.19% 129
2024
Q2 		$14.9M Sell
252,527
-50,475
-17% -$3.16M 0.23% 104
2024
Q1 		$24.2M Sell
303,002
-19,241
-6% -$1.47M 0.38% 82
2023
Q4 		$25.4M Sell
322,243
-11,867
-4% -$845K 0.43% 66
2023
Q3 		$23.3M Buy
334,110
+30,927
+10% +$2.19M 0.43% 66
2023
Q2 		$21M Buy
303,183
+9,971
+3% +$709K 0.37% 77
2023
Q1 		$21.9M Buy
293,212
+3,726
+1% +$312K 0.42% 71
2022
Q4 		$27M Sell
289,486
-13,742
-5% -$1.33M 0.53% 56
2022
Q3 		$28.9M Buy
303,228
+16,408
+6% +$1.62M 0.59% 45
2022
Q2 		$26.6M Buy
286,820
+8,482
+3% +$828K 0.61% 50
2022
Q1 		$28.2M Buy
278,338
+5,180
+2% +$544K 0.55% 50
2021
Q4 		$28.2M Buy
273,158
+1,796
+0.7% +$166K 0.53% 56
2021
Q3 		$23M Buy
271,362
+9,169
+3% +$768K 0.48% 60
2021
Q2 		$21.9M Buy
262,193
+776
+0.3% +$63.5K 0.52% 54
2021
Q1 		$19.7M Buy
261,417
+48,462
+23% +$3.53M 0.51% 55
2020
Q4 		$14.5M Buy
212,955
+6,719
+3% +$437K 0.44% 66
2020
Q3 		$12M Buy
206,236
+6,015
+3% +$374K 0.44% 63
2020
Q2 		$13M Buy
200,221
+3,005
+2% +$189K 0.52% 58
2020
Q1 		$11.7M Buy
197,216
+4,633
+2% +$309K 0.55% 55
2019
Q4 		$14.3M Buy
192,583
+1,532
+0.8% +$108K 0.58% 56
2019
Q3 		$12.1M Buy
191,051
+15,918
+9% +$943K 0.52% 63
2019
Q2 		$9.54M Buy
175,133
+7,474
+4% +$402K 0.41% 74
2019
Q1 		$9.04M Buy
167,659
+1,241
+0.7% +$76.6K 0.41% 75
2018
Q4 		$10.9M Sell
166,418
-1,551
-0.9% -$116K 0.56% 58
2018
Q3 		$13.2M Buy
167,969
+18,185
+12% +$1.3M 0.65% 55
2018
Q2 		$9.64M Buy
149,784
+3,171
+2% +$209K 0.5% 69
2018
Q1 		$9.12M Sell
146,613
-20,629
-12% -$1.48M 0.49% 67
2017
Q4 		$12.1M Sell
167,242
-11,170
-6% -$812K 0.65% 59
2017
Q3 		$14.5M Sell
178,412
-11,715
-6% -$927K 0.83% 39
2017
Q2 		$15.3M Sell
190,127
-15,119
-7% -$1.19M 0.91% 34
2017
Q1 		$16.1M Sell
205,246
-3,021
-1% -$241K 0.99% 30
2016
Q4 		$16.4M Sell
208,267
-8,994
-4% -$728K 1.07% 27
2016
Q3 		$19.3M Buy
217,261
+2,865
+1% +$270K 1.29% 18
2016
Q2 		$20.5M Buy
214,396
+3,143
+1% +$313K 1.42% 15
2016
Q1 		$21.9M Buy
211,253
+11,637
+6% +$1.13M 1.54% 13
2015
Q4 		$19.5M Buy
199,616
+7,114
+4% +$697K 1.37% 17
2015
Q3 		$18.6M Buy
192,502
+5,416
+3% +$569K 1.39% 17
2015
Q2 		$19.6M Sell
187,086
-2,148
-1% -$219K 1.37% 19
2015
Q1 		$19.5M Buy
189,234
+1,534
+0.8% +$155K 1.35% 21
2014
Q4 		$18.1M Buy
187,700
+17,594
+10% +$1.55M 1.27% 22
2014
Q3 		$13.5M Buy
170,106
+1,898
+1% +$150K 1.01% 31
2014
Q2 		$12.7M Buy
168,208
+3,160
+2% +$239K 0.95% 31
2014
Q1 		$12.4M Buy
165,048
+1,910
+1% +$135K 0.97% 30
2013
Q4 		$11.7M Buy
163,138
+1,173
+0.7% +$75.4K 0.94% 33
2013
Q3 		$9.19M Buy
161,965
+8,752
+6% +$522K 0.81% 38
2013
Q2 		$8.76M Buy
+153,213
New +$8.88M 0.8% 39

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Peapack-Gladstone Financial Corp's CVS Position: Q1 2026 in Review

Peapack-Gladstone Financial Corp reduced its CVS Health (CVS) stake by 1.4% in Q1 2026, selling an estimated $150K and leaving 142,327 shares worth $10.2M. The position accounts for 0.13% of the portfolio, ranked #163.

Peapack-Gladstone Financial Corp first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $28.9M in Q3 2022. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Peapack-Gladstone Financial Corp held 142,327 shares of CVS Health worth $10.2M as of Q1 2026.
  • Peapack-Gladstone Financial Corp sold 1,951 CVS Health shares in Q1 2026, an estimated $150K.
  • CVS Health made up 0.13% of Peapack-Gladstone Financial Corp's portfolio in Q1 2026, its #163 holding.
  • Peapack-Gladstone Financial Corp first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Peapack-Gladstone Financial Corp's CVS Health position peaked at $28.9M in Q3 2022.
  • 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2026, filed 15 May 2026.